Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Mendus Announces Financing Commitments Totaling Up to SEK 250 Million With Van Herk Investments and Negma Group
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today announces […]
Athos Therapeutics Announces Proteomics Research Collaboration for Inflammatory Bowel Disease with Caltech
Athos Therapeutics, Inc. (“Athos”) is a late-stage preclinical biotech company using Artificial Intelligence (AI) to […]
PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb
PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. […]
UltraSight Receives CE Mark for Novel Cardiac AI Technology
UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, […]
Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]
LumaBridge and Parker Institute for Cancer Immunotherapy Announce Strategic Alliance to Streamline Immunotherapy Development
LumaBridge (formerly known as Cancer Insight), a clinical research organization (CRO) dedicated to discovering, developing, and […]
BrainVectis, a Subsidiary of AskBio, Receives Clearance to Conduct Phase I/II Clinical Trial in France for Its Novel Gene Therapy for Early-stage Huntington’s Disease
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has […]
New Mobile Friendly Web Tool With Interactive Dashboard Gives Individuals the Information They Need on Monkeypox in Advance of Attending Gatherings
Summer is a time when many of us are keen to get away, enjoy the […]
Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight Against Cancer and Other Diseases
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Digital LightCyclerⓇ System, Roche’s first […]
Gilead Announces First Global Regulatory Approval of Sunlenca® (Lenacapavir), the Only Twice-yearly HIV Treatment Option
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted Marketing […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more